AstraZeneca has agreed on contract manufacturing of original pharmaceuticals with an investment volume of $32 million
The Kazakh side proposed ACDIMA to establish a regional hub in the country
Chairman of the Polpharma Group Supervisory Board Jerzy Starak talks about the company’s roadmap in Kazakhstan and future exports to the EU
